Researchers
Developing Educational Animations on HIV Pre-Exposure Prophylaxis (PrEP) for Women: Qualitative Study
This journal discusses the development of educational animations aimed at increasing awareness and understanding of HIV pre-exposure prophylaxis (PrEP) for women. The study explores qualitative research on how these animations can effectively communicate PrEP’s benefits, addressing barriers to its use and promoting better health decision-making. The research emphasizes the potential of digital health interventions in improving HIV prevention and the role of tailored educational content for enhancing women’s engagement with PrEP.
Vaginitis and Risk of Sexually Transmitted Infections: Results of a Multi-Center U.S. Clinical Study Using STI Nucleic Acid Amplification Testing
This journal investigates the prevalence of sexually transmitted infections (STIs) among women with vaginitis symptoms in a U.S. clinical study. Findings highlight the link between STIs and vaginal dysbiosis, emphasizing the need for comprehensive STI testing in this population.
Study Finds Lack of Testing for Gonorrhea, Chlamydia During Pregnancy
This webpage highlights a recent study that reveals gaps in gonorrhea and chlamydia testing during pregnancy. It emphasizes the potential health risks these infections pose to both mother and child, urging the need for improved screening protocols. The study underscores the importance of regular prenatal testing to ensure better health outcomes for both.
Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus — Region of the Americas, 2012–2022
This report outlines the progress made toward the elimination of mother-to-child transmission of hepatitis B virus in the Region of the Americas from 2012 to 2022. It highlights key strategies, achievements, and challenges in achieving the goal of reducing the transmission rates, providing a comprehensive overview of regional efforts to combat this public health issue.
Policies for Expanding Hepatitis C Testing and Treatment in United States Prisons and Jails
This report proposes policies for expanding access to hepatitis C (HCV) testing and treatment in United States jails and prisons. The report's policy recommendations draw principally from settlement agreements, judicial opinions, and other filings in those cases, supplemented by current medical guidance and input from public health experts, medical professionals, and advocates.
What You Need to Know About the New Hepatitis C Test
This article highlights a new hepatitis C test that delivers rapid results without requiring a separate lab visit, improving access to early diagnosis and treatment. It emphasizes the importance of expanding testing efforts, particularly for high-risk populations, to support hepatitis C elimination. The article underscores the need for continued innovation in screening technologies to reduce barriers to care and prevent long-term health complications like liver disease and cancer.
Study Challenges Assumptions About How Tuberculosis Bacteria Grow
This webpage highlights groundbreaking research on tuberculosis (TB) bacteria, which reveals that TB exhibits a consistent growth rate throughout its life cycle, defying conventional bacterial growth patterns. The study uncovers new insights into TB’s survival strategies, emphasizing the need for research directly on pathogens to improve treatment approaches.
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use.
Growing Awareness: Limited Testing and Screening Bias for Hepatitis Delta Virus Webinar
In this webinar, Dr. Melodie Weller of University of Utah Health System discusses the epidemiology and screening patterns for Hepatitis Delta Virus in Utah over a 22-year period.
